Blockchain Registration Transaction Record

Onco-Innovations Merges Biology, Drug Delivery, and AI in Cancer Fight

Onco-Innovations (ONCO, ONNVF) combines PNKP inhibitor ONC010, nanoparticle delivery, and AI from Inka Health to tackle cancer drug resistance, trial failures, and toxicity. Read more.

Onco-Innovations Merges Biology, Drug Delivery, and AI in Cancer Fight

This news matters because cancer drug development remains plagued by high failure rates, toxicity, and resistance. Onco-Innovations' integrated approach—combining a novel PNKP inhibitor, nanoparticle delivery, and AI-driven trial design—could accelerate the development of more effective and safer therapies. For patients and investors, this represents a potential shift toward smarter, precision-driven oncology that addresses long-standing bottlenecks in the field.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x2777dcdb1fb861c0675eeaf7989ea48d3aa64246e8ea3e1f9acaf30f331e4113
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintmail0xcu-41acef5a8e5d9f148fbcf956fceba6ca